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Sunday, February 21, 2010 123aparalleled by impaired Kþ coordination in the selectivity filter (Choi et al.,
1991; Hoshi et al., 1990; Lopez-Barneo et al., 1993). The mechanism of
KCNQ1 inactivation and its modulation by external Kþ are dissimilar to the
mechanism described for C-type inactivation in Shaker-like Kþ channels (Gi-
bor et al., 2007). Further, inactivation of wild-type (WT) KCNQ1 channels be-
comes evident only in the characteristic hooked tail currents which reflect re-
covery from inactivation (Abitbol et al., 1999; Pusch et al., 1998; Tristani-
Firouzi and Sanguinetti, 1998). We use a combination of functional-structural
analysis combined with mathematical and 3D-structural modeling to gain in-
sights into the structural rearrangements during KCNQ1-inactivation. We
show that the Kv7.1 a-subunits act in a concerted way to initiate KCNQ1-in-
activation.
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The response of voltage-dependent Kþ (Kv) channels to a change in membrane
voltage involves a molecular device, which couples voltage-driven conforma-
tional changes to gate opening and closing within the channel’s conduction
pathway. To further our understanding of the coupling choreography we
have studied how changes in coupling strength instigate the Kv channel to
open before and after voltage-sensor activation. We used single and double mu-
tations in a Kv channel pore domain to analyze coupling sensitive sites. We ob-
served in the mutational effects a correlation between coupling strength and
non-obligatory Kv channel gating that is well described with a four-state allo-
steric gating model. Mapping the data onto known Kv channel structures
showed that coupling-sensitive amino acid residues are strategically clustered
to a small area between pore gate and the interface of pore and voltage sensors.
We propose that the physical contact at the interface between voltage sensor
and pore domain is an important determinant of altered coupling strengths lead-
ing to obligatory and non-obligatory Kv channel gating.
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Members of the KCNQ (Kv7) voltage-gated potassium channel gene family are
differentially expressed through the body. Five Kv7 subtypes play major roles
in regulation of membrane potential and cell excitability within different tis-
sues. Well known functions of Kv7.1 in cardiac action potential duration,
Kv7.2/7.3 in neuronal excitability, Kv7.4 in hearing and an emerging role of
Kv7.5 in vascular tone, increases the demand for channel modulating drugs
that exhibit selectivity among Kv7 subtypes. Diclofenac, an anti-inflammatory
drug, was found to be a novel Kv7.2/7.3 channel opener and was used as a tem-
plate to synthesize new activators and inhibitors of neuronal KCNQ channels
(Kv7.2/7.3 and Kv7.4). We compare affects of diclofenac on human Kv7.4
and Kv7.5 currents using A7r5 rat aortic smooth muscle cells as an expression
system and perforated patch-clamp techniques. Diclofenac, at 100˛1/4M, in-
creased maximal conductance of Kv7.4 channels by 1.5-fold and induced a neg-
ative shift in the activation curve (by 9mV). Surprisingly, the same concentra-
tion of diclofenac (100˛1/4M) reduced maximal conductance of Kv7.5
channels by 2-fold, but also induced a robust negative shift in the activation
curve (by 30mV). For the both Kv7.4 and Kv7.5, application of diclofenac
(100˛1/4M) reduced the deactivation rate of the current. For Kv7.4, the deac-
tivation rate was 1.7-fold slower in the presence of diclofenac, independent of
the voltage in the range from 120mV to 90mV. In contrast, for Kv7.5 the
reduced deactivation rate in the presence of diclofenac was voltage-dependent,
changing linearly from 2-fold at 120mV to 4-fold at 90mV. These differ-
ences in diclofenac action on two members of the Kv7 channel family may re-
flect structural differences between Kv7.4 and Kv7.5 and make diclofenac
a useful tool to distinguish between Kv7.4 and Kv7.5 currents in native tissues.Ca-Activated Channels
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of Nevada, Reno, Reno, NV, USA.Calcium-activated chloride channels (CACCs) share common pharmacological
properties with SLO (KCNMA1)-encoded large conductance Kþ channels
(KCa1.1) and it has been suggested they may co-exist in a macromolecular com-
plex (Greenwood, I. A., and Leblanc, N. Trends Pharmacol Sci28: 1-5, 2007;
Saleh et al. J Pharmacol Exp Ther 321: 1075-1084, 2007; Sones et al. Br J
Pharmacol 158: 521-531, 2009). As KCa1.1 channels are known to localise
to cholesterol and caveolin-rich lipid rafts (caveolae) the present study investi-
gated whether Ca2þ-sensitive Cl- currents in vascular myocytes were affected
by the cholesterol depleting agent Beta-methyl cyclodextrin (Beta-MCD).
Calcium-activated chloride and potassium currents were recorded from single
murine portal vein myocytes in whole cell voltage clamp. Western blot was
undertaken following sucrose gradient ultracentrifugation using protein ly-
sates from whole portal veins. Ca2þ-activated Cl- currents were augmented
by Beta-MCD with a rapid time-course (t0.5 ¼ 1.8 min). Beta-MCD had no
effect on the bi-modal response to niflumic acid or anthracene-9-carboxylate
but completely removed the inhibitory effects of the KCa1.1 blocker paxilline
and the stimulatory effect of the KCa1.1 activator NS1619. Discontinuous
sucrose density gradients followed by Western blot analysis revealed that
KCa1.1 was present in lipid fractions, co-localising with lipid raft markers
caveolin and flotillin-2. The newly identified candidate for calcium-activated
chloride channels TMEM16A, co-localised to the same fractions as KCa1.1.
These data reveal that CACC properties are influenced by lipid raft integrity.
The results also provide a structural basis explaining the intimate functional
interaction that exist between KCa1.1 and CACCs in generating STOCs and
STICs and how they regulate resting membrane potential and tone in vascular
myocytes.643-Pos
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Pulmonary arterial hypertension (PAH) in humans is defined by a pulmonary
artery pressure (PAP) exceeding 25 mm Hg at rest, and 30 mm Hg during
physical activity. Three major factors contribute to elevating PAP in PAH pa-
tients: 1) enhanced vasoconstriction; 2) reduction of lumen diameter due to
remodeling of the arterial wall; and 3) enhanced clot formation. It has been
recently suggested that Cl- currents can regulate proliferation of cultured rat
pulmonary artery (PA) smooth muscle cells (Liang et al., Hypertension 54:
286-293, 2009). The purpose of the present study was to determine if
Ca2þ-activated Cl- currents (ICl(Ca)) are altered in PA smooth muscle cells
from monocrotaline(MCT)-treated rats. Aged-matched male rats were either
injected with saline or a single dose of MCT (50 mg/kg) to induce PAH,
and the animals from both groups were sacrificed after 3 weeks. Rats treated
with MCT displayed an increase in right ventricular weight with no change in
left ventricular and septum weights, consistent with PAH. Patch clamp exper-
iments revealed that the cell capacitance, an index of cell surface, of PA cells
from MCT-injected rats was 40% greater than that of cells from saline-in-
jected rats. Time- and voltage-dependent ICl(Ca) elicited by 500 nM internal
free Ca2þ (buffered with 10 mM BAPTA) displayed outward rectification
in both groups but was more than ~ 2-fold larger in the MCT vs. saline group.
In both groups, the current ran down over time but significantly more on a per-
centage basis in MCT than control cells. In conclusion, the properties and reg-
ulation of ICl(Ca) appear to be altered in a validated animal model of PAH and
these results suggest that this anion current may represent a new therapeutic
target.
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Ca2þ-dependent Cl- currents (IClCa) are inhibited by phosphorylation in arterial
smooth muscle cells. We recently reported that niflumic acid (NFA), an inhib-
itor of IClCa, is less efficacious at blocking these currents in conditions promot-
ing phosphorylation (Wiwchar et al., Br J Pharmacol, in press, 2009). This
